Annual D&A
$6.75 M
+$1.30 M+23.79%
December 31, 2024
Summary
- As of March 10, 2025, VERV annual depreciation & amortization is $6.75 million, with the most recent change of +$1.30 million (+23.79%) on December 31, 2024.
- During the last 3 years, VERV annual D&A has risen by +$5.22 million (+339.93%).
- VERV annual D&A is now at all-time high.
Performance
VERV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.70 M
-$54.00 K-3.08%
December 1, 2024
Summary
- As of March 10, 2025, VERV quarterly depreciation & amortization is $1.70 million, with the most recent change of -$54.00 thousand (-3.08%) on December 1, 2024.
- Over the past year, VERV quarterly D&A has stayed the same.
- VERV quarterly D&A is now -3.08% below its all-time high of $1.75 million, reached on September 30, 2024.
Performance
VERV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$6.75 M
+$183.00 K+2.79%
December 1, 2024
Summary
- As of March 10, 2025, VERV TTM depreciation & amortization is $6.75 million, with the most recent change of +$183.00 thousand (+2.79%) on December 1, 2024.
- Over the past year, VERV TTM D&A has stayed the same.
- VERV TTM D&A is now at all-time high.
Performance
VERV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VERV Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.8% | 0.0% | 0.0% |
| 3 y3 years | +339.9% | +15.3% | +38.9% |
| 5 y5 years | +6270.8% | +15.3% | +38.9% |
VERV Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +339.9% | -3.1% | +260.2% | at high | +339.9% |
| 5 y | 5-year | at high | +6270.8% | -3.1% | +930.3% | at high | +3992.7% |
| alltime | all time | at high | +6270.8% | -3.1% | +930.3% | at high | +3992.7% |
Verve Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $6.75 M(+23.8%) | - | - |
| Dec 2024 | - | $1.70 M(-3.1%) | $6.75 M(+2.8%) |
| Sep 2024 | - | $1.75 M(+5.2%) | $6.57 M(+4.5%) |
| Jun 2024 | - | $1.67 M(+2.1%) | $6.29 M(+5.5%) |
| Mar 2024 | - | $1.63 M(+7.6%) | $5.96 M(+9.3%) |
| Dec 2023 | $5.46 M(+94.5%) | $1.52 M(+2.9%) | $5.46 M(+12.2%) |
| Sep 2023 | - | $1.47 M(+10.2%) | $4.86 M(+18.4%) |
| Jun 2023 | - | $1.34 M(+18.6%) | $4.11 M(+20.2%) |
| Mar 2023 | - | $1.13 M(+21.8%) | $3.42 M(+21.9%) |
| Dec 2022 | $2.80 M | $925.00 K(+29.0%) | $2.80 M(+19.3%) |
| Sep 2022 | - | $717.00 K(+10.6%) | $2.35 M(+14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $648.00 K(+26.1%) | $2.05 M(+16.6%) |
| Mar 2022 | - | $514.00 K(+8.9%) | $1.75 M(+14.3%) |
| Dec 2021 | $1.53 M(+15.6%) | $472.00 K(+14.6%) | $1.53 M(+16.6%) |
| Sep 2021 | - | $412.00 K(+15.4%) | $1.32 M(-13.9%) |
| Jun 2021 | - | $357.00 K(+21.4%) | $1.53 M(+4.9%) |
| Mar 2021 | - | $294.00 K(+16.2%) | $1.46 M(+9.7%) |
| Dec 2020 | $1.33 M(+1152.8%) | - | - |
| Dec 2020 | - | $253.00 K(-59.5%) | $1.33 M(+23.5%) |
| Sep 2020 | - | $624.00 K(+118.2%) | $1.07 M(+138.4%) |
| Jun 2020 | - | $286.00 K(+73.3%) | $451.00 K(+173.3%) |
| Mar 2020 | - | $165.00 K | $165.00 K |
| Dec 2019 | $106.00 K | - | - |
FAQ
- What is Verve Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Verve Therapeutics?
- What is Verve Therapeutics annual D&A year-on-year change?
- What is Verve Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Verve Therapeutics?
- What is Verve Therapeutics quarterly D&A year-on-year change?
- What is Verve Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Verve Therapeutics?
- What is Verve Therapeutics TTM D&A year-on-year change?
What is Verve Therapeutics annual depreciation & amortization?
The current annual D&A of VERV is $6.75 M
What is the all time high annual D&A for Verve Therapeutics?
Verve Therapeutics all-time high annual depreciation & amortization is $6.75 M
What is Verve Therapeutics annual D&A year-on-year change?
Over the past year, VERV annual depreciation & amortization has changed by +$1.30 M (+23.79%)
What is Verve Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VERV is $1.70 M
What is the all time high quarterly D&A for Verve Therapeutics?
Verve Therapeutics all-time high quarterly depreciation & amortization is $1.75 M
What is Verve Therapeutics quarterly D&A year-on-year change?
Over the past year, VERV quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Verve Therapeutics TTM depreciation & amortization?
The current TTM D&A of VERV is $6.75 M
What is the all time high TTM D&A for Verve Therapeutics?
Verve Therapeutics all-time high TTM depreciation & amortization is $6.75 M
What is Verve Therapeutics TTM D&A year-on-year change?
Over the past year, VERV TTM depreciation & amortization has changed by $0.00 (0.00%)